Consolidated Statements of Comprehensive (Loss) Income (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Other Comprehensive Income [Abstract]
Net (loss) income	$ (23,944)	$ (50,526)	$ 97,573	$ (175,278)
Less: Net loss attributable to non-controlling interests	11,948	33,624	5,498	110,495
Net (loss) income attributable to Amneal Pharmaceuticals, Inc.	(11,996)	(16,902)	103,071	(64,783)
Foreign currency translation adjustments:
Foreign currency translation adjustments arising during the period	(2,967)	(6,219)	(8,102)	(983)
Less: Reclassification of foreign currency translation adjustment included in net loss	0	40	0	3,413
Foreign currency translation adjustments, net	(2,967)	(6,179)	(8,102)	2,430
Unrealized loss on cash flow hedge, net of tax	(9,774)	0	(72,432)	0
Less: Other comprehensive loss (income) attributable to non-controlling interests	6,471	3,533	40,927	(1,394)
Other comprehensive (loss) income attributable to Amneal Pharmaceuticals, Inc.	(6,270)	(2,646)	(39,607)	1,036
Comprehensive (loss) income attributable to Amneal Pharmaceuticals, Inc.	$ (18,266)	$ (19,548)	$ 63,464	$ (63,747)